Status:
COMPLETED
Impact of Support Groups for Patients With Non-Cystic Fibrosis Bronchiectasis
Lead Sponsor:
University of California, San Francisco
Conditions:
Non-cystic Fibrosis Bronchiectasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
BronchConnect is a prospective trial to investigate the impact of support groups on health care related quality of life in those with noncystic fibrosis bronchiectasis (NCFBE). It has been well demons...
Detailed Description
Non-cystic fibrosis bronchiectasis (NCFBE) is a chronic disease of the airways characterized by progressive damage to the airways that impairs the ability to clear mucus leading to repeated cycles of ...
Eligibility Criteria
Inclusion
- Diagnosis of bronchiectasis on computed tomography (CT) chest scan
- Bronchiectasis is the primary respiratory disease as determined by a clinician
Exclusion
- Age \< 18 years old
- Cystic fibrosis
- Traction bronchiectasis in the context of pulmonary fibrosis
- Solid organ transplant recipient
- Ability to provide informed consent
- Due to constraints of this pilot study, inability to engage in a full conversation in English
Key Trial Info
Start Date :
April 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 2 2025
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT06164470
Start Date
April 1 2024
End Date
April 2 2025
Last Update
April 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco
San Francisco, California, United States, 94143